The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Gene Rearrangement in Lung Cancer

被引:22
|
作者
Sullivan, Harold C. [1 ]
Fisher, Kevin E. [1 ]
Hoffa, Anne L. [1 ]
Wang, Jason [1 ]
Saxe, Debra [1 ]
Siddiqui, Momin T. [1 ]
Cohen, Cynthia [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
EML4-ALK; lung; adenocarcinoma; immunohistochemistry; fluorescence in situ hybridization; POLYMERASE CHAIN-REACTION; IN-SITU HYBRIDIZATION; ALK REARRANGEMENT; FUSION GENE; IDENTIFICATION; TRANSCRIPTS; INHIBITOR; CARCINOMA; AGREEMENT; EGFR;
D O I
10.1097/PAI.0000000000000088
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Background: Among the mutations described in non-small cell lung carcinoma is a rearrangement resulting from an inversion within chromosome 2p leading to the formation of a fusion gene, echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK). Fluorescence in situ hybridization (FISH) is the gold standard for the detection of ALK gene rearrangements. However, molecular methods are not readily available in all pathology laboratories. Immunohistochemistry (IHC) using an antibody directed against the EML4-ALK fusion protein provides a widely available alternative method of detection. We assessed whether IHC is a comparable and cost-effective alternative to FISH analysis for the detection of ALK gene rearrangements. Design: A total of 110 non-small cell lung carcinoma cases (63 surgical/biopsy and 47 cytology specimens), previously tested for ALK gene rearrangements by FISH [7 (6.4%) positive for the rearrangement], were probed for the EML4-ALK fusion protein using a monoclonal EML4-ALK antibody, clone 5A4. Cells were considered to stain positive for ALK if >5% of cells showed cytoplasmic staining of at least grade 1 intensity (scale: 0 to 3). A cost analysis was performed using ALK IHC as a screening test. Results: The sensitivity and specificity of the EML4-ALK IHC stain compared with ALK FISH analysis were 100% and 96%, respectively. All 7 FISH-positive cases stained positive by IHC, whereas 4 FISH-negative cases demonstrated positive staining. One of the 4 FISH-negative, IHC-positive cases harbored an EML4-ALK rearrangement by RT-PCR yielding 3 false-positive results overall. The kappa agreement between IHC and FISH methods is 0.76 (substantial/excellent). The potential savings of implementing the ALK IHC as a screening method would be $10,418.21. Conclusions: Sensitivity of the EML4-ALK IHC stain is excellent (100%) but due to its suboptimal specificity, IHC cannot reliably supplant FISH analysis for the detection of ALK gene rearrangements. IHC shows promise as a screening tool to prevent unnecessary costly FISH analysis.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 50 条
  • [1] The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Rearrangement Status in Lung Cancer
    Sullivan, H. C.
    Siddiqui, M. T.
    Wang, J.
    Cohen, C.
    LABORATORY INVESTIGATION, 2013, 93 : 468A - 468A
  • [2] The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Rearrangement Status in Lung Cancer
    Sullivan, H. C.
    Siddiqui, M. T.
    Wang, J.
    Cohen, C.
    MODERN PATHOLOGY, 2013, 26 : 468A - 468A
  • [3] Endometrial cancer with an EML4-ALK rearrangement
    Craig, Jeffrey W.
    Quade, Bradley J.
    Muto, Michael G.
    MacConaill, Laura E.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2018, 4 (04):
  • [4] Endobronchial Metastases in Lung Cancer Harboring EML4-ALK Rearrangement
    Ijichi, Miharu
    Fukuda, Yosuke
    Kashima, Ayaka
    Sagara, Hironori
    INTERNAL MEDICINE, 2023, 62 (13) : 2021 - 2022
  • [5] Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina
    Verzura, Maria
    Batagelj, Emilio
    Bagnes, Claudia
    Martin, Claudio
    Enrico, Diego
    Richardet, Eduardo
    De la Iglesia, Paola
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 : 77 - 81
  • [6] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
    Koivunen, Jussi P.
    Mermel, Craig
    Zejnullahu, Kreshnik
    Murphy, Carly
    Lifshits, Eugene
    Holmes, Alison J.
    Choi, Hwan Geun
    Kim, Jhingook
    Chiang, Derek
    Thomas, Roman
    Lee, Jinseon
    Richards, William G.
    Sugarbaker, David J.
    Ducko, Christopher
    Lindeman, Neal
    Marcoux, J. Paul
    Engelman, Jeffrey A.
    Gray, Nathanael S.
    Lee, Charles
    Meyerson, Matthew
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283
  • [7] MONO INSTITUTIONAL EXPERIENCE IN NON SMALL LUNG CANCER WITH EML4-ALK REARRANGEMENT
    Perez Mesa, Pablo Jose
    Guadalupe Pallotta, Maria
    De La Iglesia, Paola
    Lupinacci, Lorena
    Liliana Dalurzo, Mercedes
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S170 - S170
  • [8] EML4-ALK Fusion in Lung
    Mano, Hiroyuki
    Takeuchi, Kengo
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1552 - 1553
  • [9] The frequency of EML4-ALK gene rearrangement in primary lung adenocarcinoma cases of Turkish patients
    Kaya, H.
    Bozkurtlar, E.
    Kombak, E.
    Toper, H.
    VIRCHOWS ARCHIV, 2014, 465 : S322 - S322
  • [10] Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma
    Wang, Qiushi
    Yang, Xin
    He, Yong
    Ma, Qiang
    Lin, Li
    Fu, Ping
    Xiao, Hualiang
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (05): : 515 - 520